Common variation in GPC5 is associated with acquired nephrotic syndrome

Koji Okamoto, Katsushi Tokunaga, Kent Doi, Toshiro Fujita, Hodaka Suzuki, Tetsuo Katoh, Tsuyoshi Watanabe, Nao Nishida, Akihiko Mabuchi, Atsushi Takahashi, Michiaki Kubo, Shiro Maeda, Yusuke Nakamura, Eisei Noiri

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Severe proteinuria is a defining factor of nephrotic syndrome irrespective of the etiology. Investigation of congenital nephrotic syndrome has shown that dysfunction of glomerular epithelial cells (podocytes) plays a crucial role in this disease. Acquired nephrotic syndrome is also assumed to be associated with podocyte injury. Here we identify an association between variants in GPC5, encoding glypican-5, and acquired nephrotic syndrome through a genome-wide association study and replication analysis (P value under a recessive model (P rec) = 6.0 × 10-11, odds ratio = 2.54). We show that GPC5 is expressed in podocytes and that the risk genotype is associated with higher expression. We further show that podocyte-specific knockdown and systemic short interfering RNA injection confers resistance to podocyte injury in mouse models of nephrosis. This study identifies GPC5 as a new susceptibility gene for nephrotic syndrome and implicates GPC5 as a promising therapeutic target for reducing podocyte vulnerability in glomerular disease.

Original languageEnglish
Pages (from-to)459-465
Number of pages7
JournalNature Genetics
Volume43
Issue number5
DOIs
Publication statusPublished - 01-05-2011

Fingerprint

Podocytes
Nephrotic Syndrome
Glypicans
Nephrosis
Genome-Wide Association Study
Wounds and Injuries
Proteinuria
Small Interfering RNA
Epithelial Cells
Odds Ratio
Genotype
Injections
Genes

All Science Journal Classification (ASJC) codes

  • Genetics

Cite this

Okamoto, K., Tokunaga, K., Doi, K., Fujita, T., Suzuki, H., Katoh, T., ... Noiri, E. (2011). Common variation in GPC5 is associated with acquired nephrotic syndrome. Nature Genetics, 43(5), 459-465. https://doi.org/10.1038/ng.792
Okamoto, Koji ; Tokunaga, Katsushi ; Doi, Kent ; Fujita, Toshiro ; Suzuki, Hodaka ; Katoh, Tetsuo ; Watanabe, Tsuyoshi ; Nishida, Nao ; Mabuchi, Akihiko ; Takahashi, Atsushi ; Kubo, Michiaki ; Maeda, Shiro ; Nakamura, Yusuke ; Noiri, Eisei. / Common variation in GPC5 is associated with acquired nephrotic syndrome. In: Nature Genetics. 2011 ; Vol. 43, No. 5. pp. 459-465.
@article{390f74e857944375af7522c74a26c445,
title = "Common variation in GPC5 is associated with acquired nephrotic syndrome",
abstract = "Severe proteinuria is a defining factor of nephrotic syndrome irrespective of the etiology. Investigation of congenital nephrotic syndrome has shown that dysfunction of glomerular epithelial cells (podocytes) plays a crucial role in this disease. Acquired nephrotic syndrome is also assumed to be associated with podocyte injury. Here we identify an association between variants in GPC5, encoding glypican-5, and acquired nephrotic syndrome through a genome-wide association study and replication analysis (P value under a recessive model (P rec) = 6.0 × 10-11, odds ratio = 2.54). We show that GPC5 is expressed in podocytes and that the risk genotype is associated with higher expression. We further show that podocyte-specific knockdown and systemic short interfering RNA injection confers resistance to podocyte injury in mouse models of nephrosis. This study identifies GPC5 as a new susceptibility gene for nephrotic syndrome and implicates GPC5 as a promising therapeutic target for reducing podocyte vulnerability in glomerular disease.",
author = "Koji Okamoto and Katsushi Tokunaga and Kent Doi and Toshiro Fujita and Hodaka Suzuki and Tetsuo Katoh and Tsuyoshi Watanabe and Nao Nishida and Akihiko Mabuchi and Atsushi Takahashi and Michiaki Kubo and Shiro Maeda and Yusuke Nakamura and Eisei Noiri",
year = "2011",
month = "5",
day = "1",
doi = "10.1038/ng.792",
language = "English",
volume = "43",
pages = "459--465",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "5",

}

Okamoto, K, Tokunaga, K, Doi, K, Fujita, T, Suzuki, H, Katoh, T, Watanabe, T, Nishida, N, Mabuchi, A, Takahashi, A, Kubo, M, Maeda, S, Nakamura, Y & Noiri, E 2011, 'Common variation in GPC5 is associated with acquired nephrotic syndrome', Nature Genetics, vol. 43, no. 5, pp. 459-465. https://doi.org/10.1038/ng.792

Common variation in GPC5 is associated with acquired nephrotic syndrome. / Okamoto, Koji; Tokunaga, Katsushi; Doi, Kent; Fujita, Toshiro; Suzuki, Hodaka; Katoh, Tetsuo; Watanabe, Tsuyoshi; Nishida, Nao; Mabuchi, Akihiko; Takahashi, Atsushi; Kubo, Michiaki; Maeda, Shiro; Nakamura, Yusuke; Noiri, Eisei.

In: Nature Genetics, Vol. 43, No. 5, 01.05.2011, p. 459-465.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Common variation in GPC5 is associated with acquired nephrotic syndrome

AU - Okamoto, Koji

AU - Tokunaga, Katsushi

AU - Doi, Kent

AU - Fujita, Toshiro

AU - Suzuki, Hodaka

AU - Katoh, Tetsuo

AU - Watanabe, Tsuyoshi

AU - Nishida, Nao

AU - Mabuchi, Akihiko

AU - Takahashi, Atsushi

AU - Kubo, Michiaki

AU - Maeda, Shiro

AU - Nakamura, Yusuke

AU - Noiri, Eisei

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Severe proteinuria is a defining factor of nephrotic syndrome irrespective of the etiology. Investigation of congenital nephrotic syndrome has shown that dysfunction of glomerular epithelial cells (podocytes) plays a crucial role in this disease. Acquired nephrotic syndrome is also assumed to be associated with podocyte injury. Here we identify an association between variants in GPC5, encoding glypican-5, and acquired nephrotic syndrome through a genome-wide association study and replication analysis (P value under a recessive model (P rec) = 6.0 × 10-11, odds ratio = 2.54). We show that GPC5 is expressed in podocytes and that the risk genotype is associated with higher expression. We further show that podocyte-specific knockdown and systemic short interfering RNA injection confers resistance to podocyte injury in mouse models of nephrosis. This study identifies GPC5 as a new susceptibility gene for nephrotic syndrome and implicates GPC5 as a promising therapeutic target for reducing podocyte vulnerability in glomerular disease.

AB - Severe proteinuria is a defining factor of nephrotic syndrome irrespective of the etiology. Investigation of congenital nephrotic syndrome has shown that dysfunction of glomerular epithelial cells (podocytes) plays a crucial role in this disease. Acquired nephrotic syndrome is also assumed to be associated with podocyte injury. Here we identify an association between variants in GPC5, encoding glypican-5, and acquired nephrotic syndrome through a genome-wide association study and replication analysis (P value under a recessive model (P rec) = 6.0 × 10-11, odds ratio = 2.54). We show that GPC5 is expressed in podocytes and that the risk genotype is associated with higher expression. We further show that podocyte-specific knockdown and systemic short interfering RNA injection confers resistance to podocyte injury in mouse models of nephrosis. This study identifies GPC5 as a new susceptibility gene for nephrotic syndrome and implicates GPC5 as a promising therapeutic target for reducing podocyte vulnerability in glomerular disease.

UR - http://www.scopus.com/inward/record.url?scp=79955465968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955465968&partnerID=8YFLogxK

U2 - 10.1038/ng.792

DO - 10.1038/ng.792

M3 - Article

C2 - 21441931

AN - SCOPUS:79955465968

VL - 43

SP - 459

EP - 465

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 5

ER -

Okamoto K, Tokunaga K, Doi K, Fujita T, Suzuki H, Katoh T et al. Common variation in GPC5 is associated with acquired nephrotic syndrome. Nature Genetics. 2011 May 1;43(5):459-465. https://doi.org/10.1038/ng.792